Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ochs

Showing results (421-430 of 541) with videos related to

Pageof 55
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|January 16, 2022
Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET RegistryBrenna LaBere, Maria J Gutierrez, Hannah Wright, et al.
Frontiers in Immunology|April 24, 2025
Integrative immunology identified interferome signatures in uveitis and systemic disease-associated uveitisDanielle Dias Munhoz, Dennyson Leandro M Fonseca, Igor Salerno Filgueiras, et al.
Frontiers in Immunology|March 6, 2018
Dried Blood Spots, an Affordable Tool to Collect, Ship, and Sequence gDNA from Patients with an X-Linked Agammaglobulinemia Phenotype Residing in a Developing CountryGesmar R S Segundo, Anh T V Nguyen, Huyen T Thuc, et al.
The Journal of Allergy and Clinical Immunology|September 13, 2011
Effect of rituximab on human in vivo antibody immune responsesMark D Pescovitz, Troy R Torgerson, Hans D Ochs, et al.
Vox Sanguinis|April 3, 2003
Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%)M Ballow, M Berger, F A Bonilla, et al.
Transplantation|February 1, 1982
Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humansK Atkinson, R Storb, H D Ochs, et al.
The Journal of Experimental Medicine|August 1, 1994
Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA)Q Zhu, M Zhang, D J Rawlings, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 10, 2018
Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label studyIsaac R Melamed, Michael Borte, Laurenz Trawnicek, et al.
The Journal of Allergy and Clinical Immunology|October 24, 2007
Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification CommitteeRaif S Geha, Luigi D Notarangelo, Jean-Laurent Casanova, et al.
Journal of Clinical Immunology|April 20, 2016
Health-Related Quality of Life and Health Resource Utilization in Patients with Primary Immunodeficiency Disease Prior to and Following 12 Months of Immunoglobulin G TreatmentJohn Routes, Beatriz Tavares Costa-Carvalho, Bodo Grimbacher, et al.
Pageof 55

Showing results (421-430 of 541) with videos related to

Sort By:
Pageof 55
The Journal of Allergy and Clinical Immunology. in Practice|January 16, 2022
Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET RegistryBrenna LaBere, Maria J Gutierrez, Hannah Wright, et al.
Frontiers in Immunology|April 24, 2025
Integrative immunology identified interferome signatures in uveitis and systemic disease-associated uveitisDanielle Dias Munhoz, Dennyson Leandro M Fonseca, Igor Salerno Filgueiras, et al.
Frontiers in Immunology|March 6, 2018
Dried Blood Spots, an Affordable Tool to Collect, Ship, and Sequence gDNA from Patients with an X-Linked Agammaglobulinemia Phenotype Residing in a Developing CountryGesmar R S Segundo, Anh T V Nguyen, Huyen T Thuc, et al.
The Journal of Allergy and Clinical Immunology|September 13, 2011
Effect of rituximab on human in vivo antibody immune responsesMark D Pescovitz, Troy R Torgerson, Hans D Ochs, et al.
Vox Sanguinis|April 3, 2003
Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%)M Ballow, M Berger, F A Bonilla, et al.
Transplantation|February 1, 1982
Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humansK Atkinson, R Storb, H D Ochs, et al.
The Journal of Experimental Medicine|August 1, 1994
Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA)Q Zhu, M Zhang, D J Rawlings, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 10, 2018
Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label studyIsaac R Melamed, Michael Borte, Laurenz Trawnicek, et al.
The Journal of Allergy and Clinical Immunology|October 24, 2007
Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification CommitteeRaif S Geha, Luigi D Notarangelo, Jean-Laurent Casanova, et al.
Journal of Clinical Immunology|April 20, 2016
Health-Related Quality of Life and Health Resource Utilization in Patients with Primary Immunodeficiency Disease Prior to and Following 12 Months of Immunoglobulin G TreatmentJohn Routes, Beatriz Tavares Costa-Carvalho, Bodo Grimbacher, et al.
Pageof 55